Synchronous multiple ipsilateral breast cancers: Implications for patient management

Pathology

Volumn 41, Issue 1, 2009, Pages 57-67

  Jain, Sanjiv ^a,b   Rezo, Angela ^a,b   Shadbolt, Bruce ^a   Dahlstrom, Jane E ^a,b  

^a CANBERRA HOSPITAL   (Australia)

^b The Australian National University   (Australia)

Author keywords

Breast; Cancer; Ipsilateral; Management; Multicentric; Multifocal; Multiple; Pathology; Synchronous

Indexed keywords

BREAST CANCER; BREAST CARCINOMA; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT; HUMAN; INTRADUCTAL CARCINOMA; LABORATORY DIAGNOSIS; MASTECTOMY; MULTIPLE CANCER; NOMENCLATURE; PATIENT CARE; PROGNOSIS; REVIEW;

EID: 57749107497     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020802563502     Document Type: Article

References (74)

1. Cheatle GL. Benign and malignant changes in duct epithelium of breast. Br J Surg 1921; 8: 285-306.
2. Cheatle GL, Cutler M. Tumours of the Breast: Their Pathology, Symptoms, Diagnosis and Treatment. Philadelphia: JB Lippincott, 1931; 161.
3. Qualheim RE, Gall EA. Breast carcinoma with multiple sites of origin. Cancer 1957; 10: 460-8.
4. Morgenstern L, Kaufman PA, Friedman NB. The case against tylectomy for carcinoma of the breast. The factor of multicentricity. Am J Surg 1975; 130: 251-8.
5. Fisher ER, Gregorio R, Redmond C, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). I. Observations concerning the multicentricity of mammary cancer. Cancer 1975; 35: 247-54.
6. Lagios MD. Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination. Cancer 1977; 40: 1726-34.
7. Schwartz GF, Patchefsky AS, Feig SA, et al. Clinically occult breast cancer. Multicentricity and implications for treatment. Ann Surg 1980; 191: 8-12.
8. Westman-Naeser S, Bengtsson E, Eriksson O, et al. Multifocal breast carcinoma. Am J Surg 1981; 142: 255-7.
9. Egan RL. Multicentric breast carcinomas: clinical-radiographicpathologic whole organ studies and 10-year survival. Cancer 1982; 49: 1123-30.
10. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985; 56: 979-90.
11. Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 1986; 57: 1717-24.
12. Tavassolli FA. Pathology of the Breast. 2nd ed. Hong Kong: Appleton and Lange, 1999; 56-8.
13. 'Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. Am J Roentgenol 2004; 183: 1149-57.
14. Dawson PJ, Baekey PA, Clark RA. Mechanisms of multifocal breast cancer: an immunocytochemical study. Hum Pathol 1995; 26: 965-9.
15. Middleton LP, Vlastos G, Mirza NQ, et al. Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer 2002; 94: 1910-6.
16. Noguchi S, Aihara T, Koyama H, et al. Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis. Cancer 1994; 74: 872-7.
17. Tsuda H, Hirohashi S. Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q. Cancer Res 1995; 55: 3395-8.
18. Teixeira MR, Pandis N, Bardi G, et al. Discrimination between multicentric and multifocal breast carcinoma by cytogenetic investigation of macroscopically distinct ipsilateral lesions. Genes Chromosomes Cancer 1997; 18: 170-4.
19. Teixeira MR, Pandis N, Bardi G, et al. Cytogenetic analysis of multifocal breast carcinomas: dectection of karyotypically unrelated clones as well as clonal similarities between tumour foci. Br J Cancer 1997; 56: 855-9.
20. Teixeira MR, Ribeiro FR, Torres L, et al. Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis. Br J Cancer 2004; 91: 775-82.
21. Wa CV, DeVries S, Chen YY, et al. Clinical application of array-based comparative genomic hybridization to define the relationship between multiple synchronous tumors. Mod Pathol 2005; 18: 591-7.
22. Dawson PJ. What is new in our understanding of multifocal breast cancer? Pathol Res Pract 1993; 189: 111-6.
23. Katz A, Strom EA, Buchholz TA, et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 2001; 50: 735-42.
24. Derebek E, Balci P, Alanyali H, et al. Detection of bilateral multifocal breast cancer using Tc-99m sestamibi imaging. The role of delayed imaging. Clin Nucl Med 1999; 24: 590-3.
25. Cwikla JB, Buscombe JR, Holloway B, et al. Can scintimammography with (99m) Tc-MIBI identify multifocal and multicentric primary breast cancer? Nucl Med Commun 2001; 22: 1287-93.
26. Moon WK, Noh DY, Im JG. Multifocal, multicentric, and contralateral breast cancers: bilateral whole-breast US in the preoperative evaluation of patients. Radiology 2002; 224: 569-76.
27. Fischer U, Zachariae O, Baum F, et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004; 14: 1725-31.
28. Wilkinson LS, Given-Wilson R, Hall T, et al. Increasing the diagnosis of multifocal primary breast cancer by the use of bilateral whole-breast ultrasound. Clin Radiol 2005; 60: 573-8.
29. Piwkowski P, Zielińska D, Kołodziejczyk A, et al. Clinical importance of (99m) Tc-MIBI mammoscintigraphy in multifocal breast lesions. Nucl Med Rev Cent East Eur 2006; 9: 144-6.
30. Spanu A, Cottu P, Manca A, et al. Scintimammography with dedicated breast camera in unifocal and multifocal/multicentric primary breast cancer detection: a comparative study with SPECT. Int J Oncol 2007; 31: 369-77.
31. Braun M, Pölcher M, Schrading S, et al. Influence of preoperative MRI on the surgical management of patients with operable breast cancer. Breast Cancer Res Treat 2008; 111: 179-87.
32. Spanu A, Chessa F, Battista Meloni G, et al. Scintimammography with high resolution dedicated breast camera and mammography in multifocal, multicentric and bilateral breast cancer detection: a comparative study. Q J Nucl Med Mol Imaging 2008; Apr 25: (Epub ahead of print).
33. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008; 26: 3248-58.
34. Drew PJ, Chatterjee S, Turnbull LW, et al. Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann Surg Oncol 1999; 6: 599-603.
35. Van Goethem M, Schelfout K, Dijckmans L, et al. MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol 2004; 14: 809-16.
36. Hlawatsch A, Teifke A, Schmidt M, et al. Preoperative assessment of breast cancer: sonography versus MR imaging. AJR 2002; 179: 1493-501.
37. Lagios MD, Westdahl PR, Rose MR. The concept and implications of multicentricity in breast carcinoma. Pathol Annu 1981; 16: 83-102.
38. Rezo A, Rodins K, Davis AJ, et al. Assessment of tumour size and its relationship to nodal involvement in multifocal and multicentric breast cancer. J Clin Oncol (ASCO Annual Meeting Abstracts) 2007; 25: 10602.
39. Sarnelli R, Squartini F. Multicentricity in breast cancer: a submacroscopic study. Pathol Annu 1986; 21: 143-58.
40. Sikand K, Lee AH, Pinder SE, et al. Sections of the nipple and quadrants in mastectomy specimens for carcinoma are of limited value. J Clin Pathol 2005; 58: 543-5.
41. Coombs NJ, Boyages J. Multifocal and multicentric breast cancer: does each focus matter? J Clin Oncol 2005; 23: 7497-502.
42. Overton K, Shadbolt B, Fadia M, et al. Detection of breast cancer in surgical specimens by trainees: what trainee characteristics matter? Pathol Int 2008; 58: A8.
43. Royal College of Pathologists of Australasia (RCPA). 2007 Trainee Handbook, 24 September. Sydney: RCPA, 2007; 51. http://www.rcpa.edu.au/public/ default.cfm (accessed 8 July 2008).
44. Faverly DR, Burgers L, Bult P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994; 11: 193-8.
45. Gump FE, Shikora S, Habif DV, et al. The extent and distribution of cancer in breasts with palpable primary tumors. Ann Surg 1986; 204: 384-90.
46. Chua B, Ung O, Taylor R, Boyages J. Frequency and predictors of axillary lymph node metastases in invasive breast cancer. ANZ J Surg 2001; 71: 723-8.
47. Andea AA, Wallis T, Newman LA, et al. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer 2002; 94: 1383-90.
48. Greene FL, Page DL, Fleming ID, et al. editors. AJCC Cancer Staging Handbook/American Joint Committee on Cancer. 6th ed. New York: Springer-Verlag, 2002; 261.
49. Andea AA, Bouwman D, Wallis T, Visscher DW. Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer 2004; 100: 20-7.
50. Fish EB, Chapman JA, Link MA. Assessment of tumor size for multifocal primary breast cancer. Ann Surg Oncol 1998; 5: 442-6.
51. Tresserra F, Rodriguez I, García-Yuste M, et al. Tumor size and lymph node status in multifocal breast cancer. Breast J 2007; 13: 68-71.
52. O'Daly BJ, Sweeney KJ, Ridgway PF, et al. The accuracy of combined versus largest diameter in staging multifocal breast cancer. J Am Coll Surg 2007; 204: 282-5.
53. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985; 312: 665-73.
54. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 1995; 333: 1444-55.
55. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-41.
56. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227-32.
57. Fisher B, Wickerham DL, Deutsch M, et al. Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings. Semin Surg Oncol 1992; 8: 153-60.
58. Schwartz GF, Veronesi U, Clough KB, et al. Consensus Conference Committee. Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy. Cancer 2006; 107: 242-50.
59. Kurniawan ED, Wong MH, Windle I, et al. Predictors of surgical margin status in breast-conserving surgery within a breast screening program. Ann Surg Oncol 2008; 15: 2542-9.
60. Solin LJ, Orel SG, Hwang WT, et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008; 26: 386-91.
61. Fowble B, Yeh IT, Schultz DJ, et al. The role of mastectomy in patients with stage I-II breast cancer presenting with gross multifocal or multicentric disease or diffuse microcalcifications. Int J Radiat Oncol Biol Phys 1993; 27: 567-73.
62. Vlastos G, Rubio IT, Mirza NQ, et al. Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer. Ann Surg Oncol 2000; 7: 581-7.
63. Rakowsky E, Klein B, Kahan E, et al. Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat 1992; 21: 121-31.
64. Pedersen L, Gunnarsdottir KA, Rasmussen BB, et al. The prognostic influence of multifocality in breast cancer patients. Breast 2004; 13: 188-93.
65. Haley MM, Garces YI, Kee AY, et al. Breast conservation therapy (BCT) in multifocal vs. unifocal early stage breast cancer patients: the Mayo experience. Int J Radiat Oncol Biol Phys 2007; 69 (Suppl): S208-9.
66. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-7.
67. Houssami N, French J, Brennan M, et al. Breast cancer - new and emerging technologies for diagnosis and management. Aust Fam Physician 2005; 34: 657-61.
68. Kumar R, Jana S, Heiba SI, et al. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. J Nucl Med 2003; 44: 7-10.
69. Goyal A, Newcombe RG, Mansel RE, et al. Sentinel lymph node biopsy in patients with multifocal breast cancer. Eur J Surg Oncol 2004; 30: 475-9.
70. Goyal A, Mansel RE. Multifocality and sentinel node biopsy in breast cancer. Eur J Surg Oncol 2004; 30: 3-4.
71. Ferrari A, Dionigi P, Rovera F, et al. Multifocality and multicentricity are not contraindications for sentinel lymph node biopsy in breast cancer surgery. World J Surg Oncol 2006; 4: 79.
72. Behm EC, Buckingham JM. Sentinel node biopsy in larger or multifocal breast cancers: to do or not to do. ANZ J Surg 2008; 78: 151-7.
73. Knauer M, Konstantiniuk P, Haid A, et al. Multicentric breast cancer: a new indication for sentinel node biopsy - a multi-institutional validation study. J Clin Oncol 2006; 24: 3374-80.
74. Australian Cancer Network Working Party. The Pathology Reporting of Breast Cancer. A Guide for Pathologists, Surgeons, Radiologists and Oncologists: Recommendations of the Australian Cancer Network Working Party. 2nd ed. North Sydney: IntraMed Educational Group, 2001.